Actively Recruiting

Phase Not Applicable
All Genders
NCT03003299

PARTNER 3 Trial - Aortic Valve-in-Valve

Led by Edwards Lifesciences · Updated on 2024-05-10

125

Participants Needed

51

Research Sites

1108 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will assess the safety and effectiveness of the SAPIEN 3/SAPIEN 3 Ultra transcatheter heart valve (THV) in patients with a failing aortic bioprosthetic valve.

CONDITIONS

Official Title

PARTNER 3 Trial - Aortic Valve-in-Valve

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Failing surgical or transcatheter bioprosthetic valve in the aortic position with moderate or worse stenosis and/or insufficiency
  • Bioprosthetic valve true internal diameter between 18.5 mm and 28.5 mm
  • New York Heart Association Functional Class II or higher
  • Heart Team agrees patient is low to intermediate risk
  • Heart Team agrees valve implantation will likely benefit the patient
  • Patient informed about the study and provides written consent
Not Eligible

You will not qualify if you...

  • Surgical or transcatheter valve in the mitral position (mitral rings allowed)
  • Severe regurgitation (greater than 3+) or stenosis of any other valve
  • Moderate or severe paravalvular regurgitation of the failing valve
  • Unstable, rocking, or structurally compromised failing valve
  • Increased risk of coronary obstruction by prosthetic leaflets
  • Increased risk of embolization of the transcatheter heart valve
  • Residual mean gradient greater than 20 mmHg after original valve implantation
  • Iliofemoral vessel anatomy not suitable for transfemoral access
  • Anatomical issues preventing safe access to ascending aorta or apex
  • Acute myocardial infarction within 30 days before enrollment
  • Cardiac procedures with permanent implant within 30 days before procedure (except pacemaker or defibrillator)
  • Planned concomitant ablation for atrial fibrillation
  • Blood disorders or bleeding risk conditions
  • Untreated significant coronary artery disease needing revascularization
  • Hemodynamic or respiratory instability requiring support within 30 days
  • Emergency interventional or surgical procedures within 30 days prior
  • Planned surgical or coronary procedures within 30 days after valve procedure
  • Hypertrophic cardiomyopathy with obstruction
  • Left ventricular ejection fraction less than 30%
  • Intracardiac mass, thrombus, or vegetation on imaging
  • Unable to tolerate antithrombotic or anticoagulation therapy
  • Allergy to iodinated contrast not manageable by premedication
  • Stroke or transient ischemic attack within 90 days
  • Symptomatic carotid or vertebral artery disease or recent carotid treatment
  • Renal insufficiency or on renal replacement therapy at screening
  • Active bacterial endocarditis within 180 days
  • Refusal of blood products
  • Life expectancy under 24 months
  • Positive pregnancy test in women of childbearing potential
  • Currently enrolled in another investigational drug or device study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 51 locations

1

Banner University Medical Center

Phoenix, Arizona, United States, 85006

Actively Recruiting

2

University of California Los Angeles

Los Angeles, California, United States, 90095

Actively Recruiting

3

Sutter Medical Center

Sacramento, California, United States, 95919

Actively Recruiting

4

Kaiser Permanente San Francisco

San Francisco, California, United States, 94115

Withdrawn

5

Stanford University Medical Center

Stanford, California, United States, 94305

Actively Recruiting

6

UC Health Northern Colorado/Medical Center of the Rockies

Loveland, Colorado, United States, 80538

Actively Recruiting

7

Hartford Hospital

Hartford, Connecticut, United States, 06102

Actively Recruiting

8

JFK Medical Center/ Atlantic Clinical Research Collaborative

Atlantis, Florida, United States, 33462

Withdrawn

9

University of Florida, Gainesville

Gainesville, Florida, United States, 32610

Withdrawn

10

Emory University Hospital

Atlanta, Georgia, United States, 30322

Actively Recruiting

11

Northwestern University Hospital

Chicago, Illinois, United States, 60611

Actively Recruiting

12

Rush University Medical Center

Chicago, Illinois, United States, 60612

Actively Recruiting

13

Northshore University HealthSystem

Evanston, Illinois, United States, 60201

Withdrawn

14

Prairie Education and Research Cooperative

Springfield, Illinois, United States, 62701

Withdrawn

15

Ochsner Clinic Foundation

New Orleans, Louisiana, United States, 70121

Actively Recruiting

16

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

17

Henry Ford Hospital

Detroit, Michigan, United States, 48202

Actively Recruiting

18

William Beaumont Hospital

Royal Oak, Michigan, United States, 48073

Withdrawn

19

University of Minnesota Medical Center

Minneapolis, Minnesota, United States, 55455

Withdrawn

20

Mayo Clinic

Rochester, Minnesota, United States, 55905

Actively Recruiting

21

Saint Luke's Hospital of Kansas City Mid America

Kansas City, Missouri, United States, 64111

Withdrawn

22

Washington University/ Barnes-Jewish Hospital

St Louis, Missouri, United States, 63110

Actively Recruiting

23

Nebraska Heart Institute

Lincoln, Nebraska, United States, 68526

Withdrawn

24

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States, 03756

Withdrawn

25

Newark Beth Israel

Newark, New Jersey, United States, 07112

Actively Recruiting

26

University of Buffalo

Buffalo, New York, United States, 14203

Withdrawn

27

Winthrop University Hospital

Mineola, New York, United States, 11501

Actively Recruiting

28

New York University (NYU) Langone Medical Center

New York, New York, United States, 10016

Withdrawn

29

Cornell University

New York, New York, United States, 10021

Actively Recruiting

30

Columbia University Medical Center/ New York Presbyterian Hospital

New York, New York, United States, 10032

Actively Recruiting

31

Carolina's Health System

Charlotte, North Carolina, United States, 28203

Withdrawn

32

NC Heart and Vascular (Rex Hospital)

Raleigh, North Carolina, United States, 27607

Withdrawn

33

The Christ Hospital

Cincinnati, Ohio, United States, 45219

Actively Recruiting

34

The Cleveland Clinic Foundation

Cleveland, Ohio, United States, 44195

Actively Recruiting

35

Oklahoma Cardiovascular Research Group

Oklahoma City, Oklahoma, United States, 73120

Withdrawn

36

Providence Heart & Vascular Institute

Portland, Oregon, United States, 97225

Actively Recruiting

37

University of Pennsylvania Hospital

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

38

Allegheny General Hospital

Pittsburgh, Pennsylvania, United States, 15212

Actively Recruiting

39

Lankenau Medical Center

Wynnewood, Pennsylvania, United States, 19096

Actively Recruiting

40

Baptist Memorial Hospital

Memphis, Tennessee, United States, 38120

Withdrawn

41

Saint Thomas Health Services

Nashville, Tennessee, United States, 37205

Withdrawn

42

Austin Heart, PLLC

Austin, Texas, United States, 78756

Withdrawn

43

Medical City Dallas Hospital

Dallas, Texas, United States, 75093

Actively Recruiting

44

The Heart Hospital Baylor Plano

Dallas, Texas, United States, 75093

Actively Recruiting

45

The University of Texas Health Science Center at Houston

Houston, Texas, United States, 77030

Actively Recruiting

46

Intermountain Medical Center

Murray, Utah, United States, 84157

Actively Recruiting

47

University of Virginia

Charlottesville, Virginia, United States, 22908

Withdrawn

48

Inova Heart and vascular Instritute (Fairfax Inova)

Fairfax, Virginia, United States, 22042

Withdrawn

49

Sentara Cardiovascular Research Institute

Norfolk, Virginia, United States, 23507

Actively Recruiting

50

University of Wisconsin - Madison

Madison, Wisconsin, United States, 53792

Withdrawn

51

St. Paul's Hospital, Providence Health Care

Vancouver, British Columbia, Canada, V6Z 1Y6

Actively Recruiting

Loading map...

Research Team

E

Edwards THV Clinical Affairs

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here